Marriott Harrison represented investors including Oxford Science Enterprises, IP Group/Kiko Ventures and Foresight WAE Technology Fund. Mixergy closed a £9.2m fundraising with investors including Oxford Science...
Mixergy’s €10 Million Fundraise
Cognassist’s £4 Million Investment From Gresham House Ventures
Marriott Harrison acted for Gresham House Ventures Gresham House Ventures made a £4 million investment into Cognassist, a leading education and neuro-inclusion provider. Founded in 2019...
Doctify’s $10 Million Growth Round
Marriott Harrison advised Beringea on the deal. Beringea added another exciting company to its portfolio as it recently welcomed Doctify, the verified feedback for healthcare specialists...
DASH Water’s £8.7 Million Series A Funding Round
Marriott Harrison advised Beringea on the deal. Joelson advised Dash Water. Transatlantic venture capital firm Beringea led a Series A funding round into seltzer company DASH...
Lucky Saint’s Series A Funding Round
Marriott Harrison advised Beringea on the investment. Lucky Saint has secured a Series A funding round of more than £10 million, led by Beringea and JamJar...
Molecular Devices, LLC’s Acquisition of Cellesce Ltd
Marriott Harrison advised the shareholders of Cellesce Ltd. Cellesce Ltd has been sold to Molecular Devices, LLC, a leading provider of high-performance life science and part of...